Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share

Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Argan (AGX) Tops Q2 EPS by 110c
• NetApp (NTAP) Tops Q1 EPS by 47c, Beats on Revenue